Maxigen Biotech Inc. (TPE:1783)
Taiwan
· Delayed Price · Currency is TWD 41.50
-1.45 (-3.38%)
Mar 9, 2026, 1:30 PM CST
Maxigen Biotech Market Cap
Maxigen Biotech has a market cap or net worth of 3.47 billion as of March 9, 2026. Its market cap has decreased by -23.03% in one year.
Market Cap
3.47B
Enterprise Value
2.73B
Revenue
792.49M
Ranking
n/a
PE Ratio
16.58
Stock Price
41.50
Market Cap Chart
Since December 23, 2013, Maxigen Biotech's market cap has decreased from 3.53B to 3.47B, a decrease of -1.69%. That is a compound annual growth rate of -0.14%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ICARES Medicus | 3.28B |
| Nang Kuang Pharmaceutical | 3.74B |
| Bionime | 3.80B |
| SciVision Biotech | 5.08B |
| St.Shine Optical | 5.55B |
| Pacific Hospital Supply | 5.91B |
| Formosa Optical Technology | 5.93B |
| Crystalvue Medical | 1.86B |